TELMISARTAN FOR TREATING CHRONIC KIDNEY DISEASE IN DOGS Russian patent published in 2025 - IPC A61K31/401 A61K31/4184 A61K45/06 A61P9/12 A61P13/12 

FIELD: veterinary science; pharmaceutics.

SUBSTANCE: group of inventions refers to pharmaceutics, namely to use of telmisartan, a pharmaceutical composition containing telmisartan and a method of treating high urine protein/creatinine ratio in dogs. Use of telmisartan or a pharmaceutically acceptable salt thereof, also a pharmaceutical composition containing telmisartan in a therapeutically effective amount for treating high urine protein/creatinine ratio (UPC) in a dog in need of such treatment, as well as a method of treating high urine protein/creatinine ratios in a dog, wherein a therapeutically effective amount of telmisartan is administered in a daily metered amount which varies during the treatment period, daily metered amount of telmisartan for the first period of time during the treatment period is at least 1.0 mg/kg of body weight, and the daily metered amount of telmisartan is increased for a second period of time after the first period of time during the treatment period, where the daily dosed amount of telmisartan is increased for the second period of time by an increase in range of 1.00 to 2.50 mg/kg of body weight.

EFFECT: above-described group of inventions enables to effectively treat dogs from high levels of protein/creatinine ratio in urine.

22 cl, 5 dwg, 4 tbl, 2 ex